Related Experiment Video
Updated: Aug 15, 2026

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
Published on: January 3, 2025
Death-associated protein kinase is activated by dephosphorylation in response to cerebral ischemia
Mehrdad Shamloo1, Liza Soriano, Tadeusz Wieloch
1AGY Therapeutics, Inc., South San Francisco, California 94080, USA. mshamloo@agyinc.com
Abstract:
Death-associated protein kinase (DAPK) is a calcium calmodulin-regulated serine/threonine protein kinase involved in ischemic neuronal death. In situ hybridization experiments show that DAPK mRNA expression is up-regulated in brain following a global ischemic insult and down-regulated in ischemic tissues after focal ischemia. DAPK is inactive in normal brain tissues, where it is found in its phosphorylated state and becomes rapidly and persistently dephosphorylated and activated in response to ischemia in vivo. A similar dephosphorylation pattern is detected in primary cortical neurons subjected to oxygen glucose deprivation or N-methyl-D-aspartate (NMDA)-induced toxicity. Both a calcineurin inhibitor, FK506, and a selective NMDA receptor antagonist, MK-801, inhibit the dephosphorylation of DAPK after in vitro ischemia. This indicates that DAPK could be activated by NMDA receptor-mediated calcium flux, activation of calcineurin, and subsequent DAPK dephosphorylation. Moreover, concomitantly to dephosphorylation, DAPK is proteolytically processed by cathepsin after ischemia. Furthermore, a selective DAPK inhibitor is neuroprotective in both in vitro and in vivo ischemic models. These results indicate that DAPK plays a key role in mediating ischemic neuronal injury.
Insights
Death-associated protein kinase (DAPK) activation, through dephosphorylation and proteolysis, contributes to ischemic neuronal death. Inhibiting DAPK demonstrates neuroprotective effects in stroke models.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Death-associated protein kinase (DAPK) is a serine/threonine kinase implicated in neuronal cell death.
- Calcium calmodulin-dependent regulation of DAPK suggests a role in cellular stress responses.
Purpose of the Study:
- To elucidate the role and activation mechanisms of DAPK in ischemic neuronal injury.
- To investigate the therapeutic potential of DAPK inhibition in stroke models.
Main Methods:
- In situ hybridization to assess DAPK mRNA expression in ischemic brain.
- In vitro studies using primary cortical neurons subjected to oxygen-glucose deprivation or NMDA toxicity.
- Pharmacological inhibition of calcineurin and NMDA receptors.
- Assessment of DAPK dephosphorylation and proteolytic processing.
- Evaluation of a selective DAPK inhibitor in in vitro and in vivo ischemic models.
Main Results:
- DAPK mRNA is upregulated after global ischemia but downregulated after focal ischemia.
- DAPK is rapidly dephosphorylated and activated in ischemic conditions, both in vivo and in vitro.
- NMDA receptor activation and calcineurin are involved in DAPK dephosphorylation.
- DAPK undergoes cathepsin-mediated proteolysis post-ischemia.
- Selective DAPK inhibition confers neuroprotection against ischemic injury.
Conclusions:
- DAPK activation, via NMDA receptor-mediated calcium influx and calcineurin, plays a critical role in ischemic neuronal death.
- DAPK is a promising therapeutic target for stroke treatment.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
cAMP-dependent Protein Kinase Pathways
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Ischemic Stroke ll: Pathophysiology
Amplifying Signals via Enzymatic Cascade
